Abstract
Nanotechnology enabled management approaches against the Covid-19 pandemic
Highlights
Coronaviruses (COVs) has been established as pathogenic virus to animals and mildly infective to humans in 1937
Previous reports on therapeutic efficacy of nanomaterials against coronaviruses and enveloped positive sense RNA viruses, can by concept be used to propose promising nanotechnology-based therapeutic target for severe acute respiratory Syndrome (SARS) CoV2
Based on the role of nanoparticles in different aspects of virology, we could infer that understanding the interface between coronavirus and nanotechnology will direct the scientists and researchers towards a new era for the impeccable design and repurposing of antiviral drugs, vaccines and effective diagnostic tools for COVID-19
Summary
Coronaviruses (COVs) has been established as pathogenic virus to animals and mildly infective to humans in 1937. Proteins and RNA genome are the structural components of SARS CoV2 involved in host interaction and infection [14]. Previous reports on therapeutic efficacy of nanomaterials against coronaviruses and enveloped positive sense RNA viruses, can by concept be used to propose promising nanotechnology-based therapeutic target for SARS CoV2.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
